BC
IMNM icon

Bayforest Capital’s Immunome IMNM Stock Holding History

Bayforest Capital’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$35.8K Buy
+1,666
New +$41.4K 0.05% 589
2026
Q2 		– Sell
-5,271
Closed -$115K – 1072
2026
Q1 		$115K Buy
+5,271
New +$117K 0.13% 310

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Alerus Financial
Alerus Financial Grand Forks, North Dakota $2.27B AUM 22.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Bayforest Capital's IMNM Position: Q3 2026 in Review

Bayforest Capital opened a new position in Immunome (IMNM) in Q3 2026: 1,666 shares worth $35.8K. The stake represents 0.05% of the portfolio and ranks #589 among its holdings. This is a return to the name: Bayforest Capital previously reported a position in IMNM as recently as Q1 2026.

Bayforest Capital first reported a position in IMNM in Q1 2026 and has held it in 2 quarters since. The position peaked at $115K in Q1 2026. 84 funds tracked by Wall St. Rank hold IMNM as of Q3 2026.

  • Bayforest Capital held 1,666 shares of Immunome worth $35.8K as of Q3 2026.
  • Immunome was a new Bayforest Capital position in Q3 2026.
  • Immunome made up 0.05% of Bayforest Capital's portfolio in Q3 2026, its #589 holding.
  • Bayforest Capital first reported a position in Immunome in Q1 2026 and has held it in 2 quarters since.
  • Bayforest Capital's Immunome position peaked at $115K in Q1 2026.
  • 84 funds tracked by Wall St. Rank held Immunome as of Q3 2026.

Based on Bayforest Capital's 13F filing for Q3 2026, filed 3 Nov 2026.